Perfect Medical Health Management Limited (HK:1830)
:1830
Want to see HK:1830 full AI Analyst Report?
Top Page
Perfect Medical Health Management Limited
(1830)
Select Model
Select Model
Rating:66Neutral
Price Target:
HK$1.50
▲(20.00% Upside)
Action:ReiteratedDate:10/17/25
The stock's overall score is driven primarily by its strong valuation, offering a low P/E ratio and high dividend yield. However, the financial performance is hindered by declining revenue and cash flow growth, and technical indicators suggest a bearish trend. The absence of earnings call data and notable corporate events limits additional insights.
Positive Factors
High profitability margins
The company’s high gross and operating margins indicate durable pricing power and a scalable service mix dominated by high-margin procedures. Strong margins support internal funding for marketing and expansion, and provide a cushion versus revenue volatility over the next 2–6 months.
Negative Factors
Declining revenue trends
Sustained revenue contraction signals weakening demand or loss of client traction in core aesthetic services. Over a multi-month horizon, lower top-line trends can reduce clinic utilization, erode operating leverage, and force trade-offs between marketing spend and margin preservation.
Read all positive and negative factors
Positive Factors
Negative Factors
High profitability margins
The company’s high gross and operating margins indicate durable pricing power and a scalable service mix dominated by high-margin procedures. Strong margins support internal funding for marketing and expansion, and provide a cushion versus revenue volatility over the next 2–6 months.
Read all positive factors
Perfect Medical Health Management Limited (1830) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.51B
Dividend Yield9.92%
Average Volume (3M)414.58K
Price to Earnings (P/E)4.6
Beta (1Y)0.68
Revenue Growth-23.31%
EPS Growth-44.61%
CountryHK
Employees1,161
SectorHealthcare
Sector Strength45
IndustryPersonal Products & Services
Share Statistics
EPS (TTM)0.07
Shares Outstanding1,256,197,800
10 Day Avg. Volume497,109
30 Day Avg. Volume414,582
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)7.51
Price to Sales (P/S)2.53
P/FCF Ratio9.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.23
Revenue Forecast (FY)HK$1.22B
Perfect Medical Health Management Limited Business Overview & Revenue Model
Company Description
Perfect Medical Health Management Limited, an investment holding company, provides medical and aesthetic medical services in Hong Kong, China, Macau, Singapore, and Australia. It offers medical beauty, hair growth, pain management, preventive care...
How the Company Makes Money
Perfect Medical Health Management Limited primarily makes money by charging customers for aesthetic medical and beauty services delivered at its service centers. Key revenue streams include: (1) service fees from individual treatments (e.g., aesth...
Perfect Medical Health Management Limited Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
60
Neutral
| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.13B | 1.39B | 1.39B | 1.35B | 1.09B |
| Gross Profit | 719.22M | 911.37M | 662.60M | 689.93M | 553.44M |
| EBITDA | 441.97M | 596.91M | 592.40M | 602.84M | 474.13M |
| Net Income | 206.90M | 315.80M | 315.64M | 305.25M | 284.63M |
Balance Sheet | |||||
| Total Assets | 935.91M | 1.22B | 1.30B | 1.28B | 1.48B |
| Cash, Cash Equivalents and Short-Term Investments | 386.80M | 567.40M | 656.85M | 454.37M | 532.89M |
| Total Debt | 216.65M | 268.73M | 240.35M | 311.07M | 261.60M |
| Total Liabilities | 557.18M | 725.00M | 684.02M | 786.93M | 795.52M |
| Stockholders Equity | 379.95M | 497.51M | 612.27M | 494.27M | 684.85M |
Cash Flow | |||||
| Free Cash Flow | 298.23M | 445.50M | 533.81M | 372.16M | 527.69M |
| Operating Cash Flow | 332.88M | 497.12M | 560.55M | 516.71M | 605.91M |
| Investing Cash Flow | -171.93M | 162.56M | -222.51M | 8.05M | -300.82M |
| Financing Cash Flow | -477.95M | -520.97M | -335.02M | -565.97M | -394.41M |
Perfect Medical Health Management Limited Technical Analysis
Positive
1.25
Price Trends
1.19
Positive
1.24
Positive
1.34
Negative
Market Momentum
<0.01
Negative
64.37
Neutral
77.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1830, the sentiment is Positive. The current price of 1.25 is above the 20-day moving average (MA) of 1.16, above the 50-day MA of 1.19, and below the 200-day MA of 1.34, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 64.37 is Neutral, neither overbought nor oversold. The STOCH value of 77.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1830.
Perfect Medical Health Management Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$700.97M | 7.71 | 23.07% | 5.98% | -0.19% | 19.04% | |
66 Neutral | HK$1.51B | 4.60 | 39.78% | 9.92% | -23.31% | -44.61% | |
63 Neutral | HK$4.65B | 21.31 | 57.32% | ― | 56.28% | -9.91% | |
62 Neutral | HK$360.00M | 33.09 | 11.41% | ― | -20.59% | ― | |
53 Neutral | HK$78.69M | 2.59 | 10.10% | ― | -3.40% | 515.63% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
HK:1830
Perfect Medical Health Management Limited
1.20
-0.79
-39.70%
HK:1161
Water Oasis Group
1.03
0.04
4.25%
HK:0919
Modern Healthcare Technology Holdings Limited
0.09
0.01
19.18%
HK:1827
Miricor Enterprises Holdings Ltd
0.90
-0.24
-21.05%
HK:8603
Fameglow Holdings Limited
5.68
4.51
385.47%
Perfect Medical Health Management Limited Corporate Events
Perfect Medical Proposes New 2026 Share Option Scheme and Major Grant to Chairman
Apr 28, 2026
Perfect Medical Health Management Limited plans to terminate its existing 2021 share option scheme and replace it with a new 2026 share option scheme aligned with the latest Chapter 17 requirements of Hong Kong’s Listing Rules. Outstanding o...
Perfect Medical Overhauls Remuneration Committee to Strengthen Governance
Apr 22, 2026
Perfect Medical Health Management Limited has reshuffled its Remuneration Committee, with executive directors Dr. Au‑Yeung Kong, Ms. Au‑Yeung Wai and Mr. So Hin Lung stepping down as committee members effective 23 April 2026. The commi...
Perfect Medical Sets New Board and Committee Line‑Up for 2026
Apr 22, 2026
Perfect Medical Health Management Limited has announced the composition of its board of directors effective 23 April 2026, reaffirming Dr. Au‑Yeung Kong as chairman and chief executive officer alongside three other executive directors and fo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.